Novel approaches to treatment of hepatocellular carcinoma and hepatic metastases using thermal ablation and thermosensitive liposomes.

PubWeight™: 0.79‹?›

🔗 View Article (PMC 3738918)

Published in Surg Oncol Clin N Am on March 13, 2013

Authors

Mark W Dewhirst1, Chelsea D Landon, Christina L Hofmann, Paul R Stauffer

Author Affiliations

1: Radiation Oncology Department, Duke University Medical Center, Durham, NC 27710, USA. Mark.dewhirst@duke.edu

Associated clinical trials:

Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC) | NCT00617981

Phase 1/2 Study of ThermoDox With Approved Hyperthermia in Treatment of Breast Cancer Recurrence at the Chest Wall (DIGNITY) | NCT00826085

Articles cited by this

Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci U S A (1991) 4.85

Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology (2001) 3.85

Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet (2000) 3.17

Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology. Lancet (1995) 3.03

A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model. Cancer Res (2000) 2.99

Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol (2010) 2.66

Design of liposomes for enhanced local release of drugs by hyperthermia. Science (1978) 2.17

Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Cancer Res (2000) 2.17

Radiofrequency and microwave ablation of the liver, lung, kidney, and bone: what are the differences? Curr Probl Diagn Radiol (2009) 2.12

Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects. J Natl Cancer Inst (2007) 2.03

Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2. Ann Oncol (2000) 2.00

Engineering liposomes for drug delivery: progress and problems. Trends Biotechnol (1995) 1.95

Liposomal doxorubicin increases radiofrequency ablation-induced tumor destruction by increasing cellular oxidative and nitrative stress and accelerating apoptotic pathways. Radiology (2010) 1.84

Re-setting the biologic rationale for thermal therapy. Int J Hyperthermia (2005) 1.82

Optimal strategies for combining transcatheter arterial chemoembolization and radiofrequency ablation in rabbit VX2 hepatic tumors. J Vasc Interv Radiol (2008) 1.57

A pilot Phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for locally advanced cervical carcinoma. Cancer (2003) 1.56

Liposomes and local hyperthermia: selective delivery of methotrexate to heated tumors. Science (1979) 1.53

Image-guided drug delivery with magnetic resonance guided high intensity focused ultrasound and temperature sensitive liposomes in a rabbit Vx2 tumor model. J Control Release (2011) 1.49

Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy. J Control Release (2009) 1.42

Hyperthermia and liposomes. Int J Hyperthermia (1999) 1.39

Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors. Cancer Res (2012) 1.38

Phase I trial of doxorubicin-containing low temperature sensitive liposomes in spontaneous canine tumors. Clin Cancer Res (2006) 1.37

Thermosensitive liposomes: extravasation and release of contents in tumor microvascular networks. Int J Radiat Oncol Biol Phys (1996) 1.32

Magnetic resonance imaging of high intensity focused ultrasound mediated drug delivery from temperature-sensitive liposomes: an in vivo proof-of-concept study. J Control Release (2010) 1.32

Targeting tumor microvessels using doxorubicin encapsulated in a novel thermosensitive liposome. Mol Cancer Ther (2004) 1.28

Radiofrequency ablation of hepatic tumors: increased tumor destruction with adjuvant liposomal doxorubicin therapy. AJR Am J Roentgenol (2002) 1.25

Radiofrequency thermal ablation sharply increases intratumoral liposomal doxorubicin accumulation and tumor coagulation. Cancer Res (2003) 1.19

Lyso-thermosensitive liposomal doxorubicin: a novel approach to enhance efficacy of thermal ablation of liver cancer. Expert Opin Pharmacother (2009) 1.19

Microwaves create larger ablations than radiofrequency when controlled for power in ex vivo tissue. Med Phys (2010) 1.18

Percutaneous radiofrequency ablation of hepatic colorectal metastases: technique, indications, results, and new promises. Invest Radiol (2004) 1.18

Doxorubicin physical state in solution and inside liposomes loaded via a pH gradient. Biochim Biophys Acta (1998) 1.18

Formulation and characterisation of magnetic resonance imageable thermally sensitive liposomes for use with magnetic resonance-guided high intensity focused ultrasound. Int J Hyperthermia (2011) 1.17

Combined radiofrequency ablation and adjuvant liposomal chemotherapy: effect of chemotherapeutic agent, nanoparticle size, and circulation time. J Vasc Interv Radiol (2005) 1.16

Combination radiofrequency thermal ablation and adjuvant IV liposomal doxorubicin increases tissue coagulation and intratumoural drug accumulation. Int J Hyperthermia (2004) 1.16

Novel temperature-sensitive liposomes with prolonged circulation time. Clin Cancer Res (2004) 1.15

Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intravenous liposomal doxorubicin in a rat breast tumor model. Radiology (2002) 1.14

Nanoscale Drug Delivery and Hyperthermia: The Materials Design and Preclinical and Clinical Testing of Low Temperature-Sensitive Liposomes Used in Combination with Mild Hyperthermia in the Treatment of Local Cancer. Open Nanomed J (2011) 1.14

Localised drug release using MRI-controlled focused ultrasound hyperthermia. Int J Hyperthermia (2010) 1.14

Mathematical spatio-temporal model of drug delivery from low temperature sensitive liposomes during radiofrequency tumour ablation. Int J Hyperthermia (2010) 1.14

Chemodosimetry of in vivo tumor liposomal drug concentration using MRI. Magn Reson Med (2006) 1.08

Hyperthermia and thermosensitive liposomes for improved delivery of chemotherapeutic drugs to solid tumors. Pharm Res (2010) 1.08

Comparative effects of thermosensitive doxorubicin-containing liposomes and hyperthermia in human and murine tumours. Int J Hyperthermia (2010) 1.08

Combination radiofrequency ablation with intratumoral liposomal doxorubicin: effect on drug accumulation and coagulation in multiple tissues and tumor types in animals. Radiology (2005) 1.02

Phase I study of heat-deployed liposomal doxorubicin during radiofrequency ablation for hepatic malignancies. J Vasc Interv Radiol (2011) 1.02

In vitro stability and content release properties of phosphatidylglyceroglycerol containing thermosensitive liposomes. Biochim Biophys Acta (2007) 1.01

Thermosensitive sterically stabilized liposomes: formulation and in vitro studies on mechanism of doxorubicin release by bovine serum and human plasma. Pharm Res (1995) 1.00

Lyso-thermosensitive liposomal doxorubicin: an adjuvant to increase the cure rate of radiofrequency ablation in liver cancer. Future Oncol (2011) 1.00

Thermosensitive polymer-modified liposomes. Adv Drug Deliv Rev (2001) 1.00

Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study. Eur J Cancer Clin Oncol (1989) 0.98

Thermosensitive chitosan-based hydrogel containing liposomes for the delivery of hydrophilic molecules. J Control Release (2002) 0.97

Laser ablation for small hepatocellular carcinoma. Radiol Res Pract (2011) 0.95

Cytotoxic effects of hyperthermia and adriamycin on Chinese hamster cells. J Natl Cancer Inst (1976) 0.94

Tolerance of high-intensity focused ultrasound ablation in patients with hepatocellular carcinoma. World J Surg (2012) 0.94

Synergy in cancer treatment between liposomal chemotherapeutics and thermal ablation. Chem Phys Lipids (2011) 0.93

Non-invasive monitoring of intra-tumor drug concentration and therapeutic response using optical spectroscopy. J Control Release (2009) 0.92

Introduction: thermal ablation therapy. Int J Hyperthermia (2004) 0.92

Percutaneous tumor ablation: reduced tumor growth with combined radio-frequency ablation and liposomal doxorubicin in a rat breast tumor model. Radiology (2003) 0.91

Hypoxia and retinoic acid-inducible NDRG1 expression is responsible for doxorubicin and retinoic acid resistance in hepatocellular carcinoma cells. Cancer Lett (2010) 0.91

Percutaneous microwave ablation of larger hepatocellular carcinoma. Clin Radiol (2012) 0.90

Enhanced delivery and antitumor activity of doxorubicin using long-circulating thermosensitive liposomes containing amphipathic polyethylene glycol in combination with local hyperthermia. Pharm Res (1994) 0.90

Stereotactic radiofrequency ablation (SRFA) of liver lesions: technique effectiveness, safety, and interoperator performance. Cardiovasc Intervent Radiol (2011) 0.89

Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer: a phase II clinical trial. Ann Surg (1998) 0.88

MR characterization of mild hyperthermia-induced gadodiamide release from thermosensitive liposomes in solid tumors. Invest Radiol (2008) 0.87

Selective delivery of liposome-associated cis-dichlorodiammineplatinum(II) by heat and its influence on tumor drug uptake and growth. Cancer Res (1981) 0.87

Cationic thermosensitive liposomes: a novel dual targeted heat-triggered drug delivery approach for endothelial and tumor cells. Nano Lett (2012) 0.86

Image-guided ablation for hepatocellular carcinoma. Recent Results Cancer Res (2013) 0.85

Thermosensitive polymer-modified liposomes that release contents around physiological temperature. Biochim Biophys Acta (1999) 0.84

Magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU) ablation of liver tumours. Cancer Imaging (2012) 0.82

A phase I/II study of combined weekly systemic cisplatin and locoregional hyperthermia in patients with previously irradiated recurrent carcinoma of the uterine cervix. Br J Cancer (1999) 0.80

Influence of ablative margin on local tumor progression and survival in patients with HCC ≤4 cm after laser ablation. Acta Radiol (2012) 0.80

The synergistic effect of hyperthermia and chemotherapy on murine transitional cell carcinoma. J Urol (1984) 0.80

RF ablation with adjuvant therapy: comparison of external beam radiation and liposomal doxorubicin on ablation efficacy in an animal tumor model. Int J Hyperthermia (2008) 0.79

Proteins and cholesterol lipid vesicles are mediators of drug release from thermosensitive liposomes. J Control Release (2012) 0.78

Repeated transarterial chemoembolisation using different chemotherapeutic drug combinations followed by MR-guided laser-induced thermotherapy in patients with liver metastases of colorectal carcinoma. Br J Cancer (2012) 0.78

Combined adriamycin and hyperthermia treatment of a murine mammary carcinoma in vivo. Cancer Res (1976) 0.77

Comparison between different thickness umbrella-shaped expandable radiofrequency electrodes (SuperSlim and CoAccess): Experimental and clinical study. Exp Ther Med (2011) 0.76

Hyperthermic potentiation of doxorubicin and 4'-epi-doxorubicin in a transplantable neurogenic rat tumor (BT4A) in BD IX rats. Int J Radiat Oncol Biol Phys (1983) 0.76

Systemic thermochemotherapy in a rat model. Can J Surg (1983) 0.76

Liposomes as drug carriers in cancer therapy: hyperthermia and pH sensitivity as modalities for targeting. Strahlentherapie (1984) 0.76

Image-guided thermal ablation of nonresectable hepatic tumors using the Cool-Tip radiofrequency ablation system. Expert Rev Med Devices (2007) 0.75

Articles by these authors

Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors. Cancer Res (2012) 1.38

Modeling the detectability of vesicoureteral reflux using microwave radiometry. Phys Med Biol (2010) 1.22

Size and conformation of Ficoll as determined by size-exclusion chromatography followed by multiangle light scattering. Am J Physiol Renal Physiol (2009) 1.15

Can we settle with single-band radiometric temperature monitoring during hyperthermia treatment of chestwall recurrence of breast cancer using a dual-mode transceiving applicator? Phys Med Biol (2007) 1.13

Therapeutic drug monitoring of piperacillin-tazobactam using spent dialysate effluent in patients receiving continuous venovenous hemodialysis. Antimicrob Agents Chemother (2010) 1.11

Catabolism of exogenous lactate reveals it as a legitimate metabolic substrate in breast cancer. PLoS One (2013) 1.07

Accuracy of real time noninvasive temperature measurements using magnetic resonance thermal imaging in patients treated for high grade extremity soft tissue sarcomas. Med Phys (2009) 1.03

Characterization of the recalcitrant CYP1 phenotype found in Atlantic killifish (Fundulus heteroclitus) inhabiting a Superfund site on the Elizabeth River, VA. Aquat Toxicol (2010) 1.01

Tumor cells upregulate normoxic HIF-1α in response to doxorubicin. Cancer Res (2013) 0.99

Utility of treatment planning for thermochemotherapy treatment of nonmuscle invasive bladder carcinoma. Med Phys (2012) 0.95

Effects of pressure and electrical charge on macromolecular transport across bovine lens basement membrane. Biophys J (2013) 0.94

Nonparametric 1-D temperature restoration in lossy media using Tikhonov regularization on sparse radiometry data. IEEE Trans Biomed Eng (2003) 0.90

Numerical 3D modeling of heat transfer in human tissues for microwave radiometry monitoring of brown fat metabolism. Proc SPIE Int Soc Opt Eng (2013) 0.90

Vesicoureteral reflux in children: a phantom study of microwave heating and radiometric thermometry of pediatric bladder. IEEE Trans Biomed Eng (2011) 0.88

Radiation dosimetry of a conformal heat-brachytherapy applicator. Technol Cancer Res Treat (2004) 0.88

Simulation techniques in hyperthermia treatment planning. Int J Hyperthermia (2013) 0.88

Design of a water coupling bolus with improved flow distribution for multi-element superficial hyperthermia applicators. Int J Hyperthermia (2009) 0.87

Miniature microwave applicator for murine bladder hyperthermia studies. Int J Hyperthermia (2012) 0.87

Flow patterns and heat convection in a rectangular water bolus for use in superficial hyperthermia. Phys Med Biol (2009) 0.86

Effective learning strategies for real-time image-guided adaptive control of multiple-source hyperthermia applicators. Med Phys (2010) 0.85

A pilot clinical trial of intravesical mitomycin-C and external deep pelvic hyperthermia for non-muscle-invasive bladder cancer. Int J Hyperthermia (2014) 0.85

Solute partitioning and filtration by extracellular matrices. Am J Physiol Renal Physiol (2009) 0.85

Components of a hyperthermia clinic: recommendations for staffing, equipment, and treatment monitoring. Int J Hyperthermia (2013) 0.83

Automatic temperature controller for multielement array hyperthermia systems. IEEE Trans Biomed Eng (2006) 0.82

The impact of temperature and urinary constituents on urine viscosity and its relevance to bladder hyperthermia treatment. Int J Hyperthermia (2013) 0.82

Size reduction and radiation pattern shaping of multi-fed DCC slot antennas used in conformal microwave array hyperthermia applicators. Proc SPIE Int Soc Opt Eng (2009) 0.82

Magnetic fluid hyperthermia for bladder cancer: a preclinical dosimetry study. Int J Hyperthermia (2013) 0.82

Molecular conformation and filtration properties of anionic Ficoll. Am J Physiol Renal Physiol (2010) 0.82

Improved hyperthermia treatment control using SAR/temperature simulation and PRFS magnetic resonance thermal imaging. Int J Hyperthermia (2010) 0.82

Thermal modelling using discrete vasculature for thermal therapy: A review. Int J Hyperthermia (2013) 0.81

The performance of a reduced-order adaptive controller when used in multi-antenna hyperthermia treatments with nonlinear temperature-dependent perfusion. Phys Med Biol (2009) 0.81

Preclinical Dosimetry of Magnetic Fluid Hyperthermia for Bladder Cancer. Proc SPIE Int Soc Opt Eng (2013) 0.81

Rational design of "heat seeking" drug loaded polypeptide nanoparticles that thermally target solid tumors. Nano Lett (2014) 0.80

A thermal monitoring sheet with low influence from adjacent waterbolus for tissue surface thermometry during clinical hyperthermia. IEEE Trans Biomed Eng (2008) 0.79

Focused ultrasound for treatment of bone tumours. Int J Hyperthermia (2015) 0.79

Luminescent difluoroboron β-diketonate PEG-PLA oxygen nanosensors for tumor imaging. Macromol Rapid Commun (2015) 0.78

Thermal dosimetry characteristics of deep regional heating of non-muscle invasive bladder cancer. Int J Hyperthermia (2014) 0.78

Systemic anti-tumour effects of local thermally sensitive liposome therapy. Int J Hyperthermia (2014) 0.75

Shaping and resizing of multifed slot radiators used in conformal microwave antenna arrays for hyperthermia treatment of large superficial diseases. Int Conf Electromagn Adv Appl (2009) 0.75

Preclinical assessment of comfort and secure fit of thermobrachytherapy surface applicator (TBSA) on volunteer subjects. J Appl Clin Med Phys (2012) 0.75

Design and optimization of an ultra wideband and compact microwave antenna for radiometric monitoring of brain temperature. IEEE Trans Biomed Eng (2014) 0.75

NIR-emissive PEG-b-TCL micelles for breast tumor imaging and minimally invasive pharmacokinetic analysis. Nanoscale (2017) 0.75

Characteristics of microstrip muscle-loaded single-arm Archimedean spiral antennas as investigated by FDTD numerical computations. IEEE Trans Biomed Eng (2005) 0.75